LivaNova PLC (LIVN)
LIVNNASDAQ-GSBiotechnology: Electromedical & Electrotherapeutic Apparatus
$90.47
-2.15 (-2.32%) today
Regular session, Nov 10, 1:57 PM ET
- Market cap
- $4.98bn
- P/E
- 24.8
- EPS, last 4 quarters
- $3.65
- Dividend yield
- –
- Day range
- $89.33 to $92.00
- 52-week range
- $49.83 to $99.38
- Average volume
- 678.7k
- Previous close
- $92.61
Analysts
7 coveringBuy6 buy, 1 hold, 0 sell
Targets a year out average $106.14, +17.3% from here
Earnings
next estimate $0.9400Next report
Dec 2025
+9.0%
Mar 2026
+20.8%
Jun 2026
+6.3%
Sep 2026
+14.4%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $360.92m | $362.26m | $390.59m | $393.15m |
| Gross profit | $239.77m | $243.75m | $273.67m | $265.05m |
| Operating income | $42.58m | $41.47m | $49.48m | $28.43m |
| Net income | $30.91m | $22.29m | $108.57m | $34.29m |
Last four quarters: revenue $1.51bn, margin 13.0%, free cash flow $129.02m
News
8 latest- LivaNova Consensus Price Target Increased by 17.90% to $107.33Fintel · 17 hours ago
- Healthcare Stocks Rally: LYEL Leads With 44% Gain; LIVN, UFPT And STIM Advance On Key Updates RTTNews · 6 days ago
- LivaNova (LIVN) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- LivaNova Q3 Earnings Call HighlightsMarketBeat · 6 days ago
- LivaNova (LIVN) Reports Q3 Earnings: What Key Metrics Have to SayZacks · 6 days ago
- LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS GuidanceFintel · 6 days ago
- LivaNova (LIVN) Surpasses Q3 Earnings and Revenue EstimatesZacks · 6 days ago
- Waters (WAT) Beats Q3 Earnings and Revenue EstimatesZacks · Nov 3, 2026
The company
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. With its registered office in the United Kingdom, approximately 3,300 employees, and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ-GS
- Region
- Europe
- Website
- livanova.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.